Question 1

What specific benefits might I expect from this combination treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression clinical trial (NCT00035321). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I be aware of with olanzapine and fluoxetine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression clinical trial (NCT00035321). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to other options available for my depression?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression clinical trial (NCT00035321). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the study visits involve, and how often will I need to come in?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression clinical trial (NCT00035321). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression clinical trial (NCT00035321). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression clinical trial (NCT00035321). Contact the study team or your healthcare provider for specific answers.

What this study is about